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EDITORIAL
The catastrophic cost of tuberculosis: advancing research and
solutions
THERE IS AVICIOUS CYCLE BETWEEN tubercu-
losis (TB) and poverty—TB is driven by poverty and
is associated with a catastrophic financial burden on
affected low-income households.1 Two recent papers
from the same study contribute important evidence in
this area.2,3 In Limpopo Province in South Africa,
28% of 323 adult TB patients experienced cata-
strophic costs.2 Applying a different measurement
method revealed high rates of deprivation (33%)
among patients and higher TB episode costs in
patients from deprived households.3
Erlinger et al.’s study confirms the burden imposed
by TB on already vulnerable individuals and house-
holds.3 It also demonstrates different approaches for
measuring catastrophic costs and stimulates debate
on persisting uncertainties about optimal measure-
ment strategies. For example, the authors highlight
self-reported income as a less reliable measure.3 The
study also provides valuable insights into the design
of the forthcoming South African national TB costs
survey. However, while methodology is important, it
is time to move the research debate from methodo-
logical issues to pragmatic solutions.
Catastrophic cost is a term peculiar to TB.
Complementing it with the concept of impoverish-
ment, as Erlinger et al. have done,3 has the potential
to advance research in this field in our opinion. Our
understanding of how to measure impoverishment is
more extensive than the notion of health-related
expenditures. Countries could follow Erlinger et al.’s
lead in relying on robust methods such as the South
African Multidimensional Poverty Index (SAMPI),4
to estimate the extent of impoverishment experienced
by TB-affected households and identify opportunities
to pilot these methods within surveys on TB-related
impoverishment. As recommended by Erlinger et al.,3
linkage to broader survey opportunities would enable
a longitudinal perspective for ascertaining whether
impoverishment is transient or chronic and determin-
ing how TB shapes the life trajectory of affected
households, including children.5
Most importantly, discussions on impoverishment
could facilitate action. In this context, Stracker et al.
acknowledge the role of social protection in address-
ing TB-related catastrophic costs.2,3 The South
African disability grant is designed as a form of social
protection for people being treated for TB, and in one
qualitative study, the grant provided a buffer against
absolute poverty during TB treatment.6 However, as
pointed out by Stracker et al., only 5% of people
being treated for TB in South Africa are reported to
have access to the local Disability Grant despite
eligibility.2 Poor access to locally available social
protection schemes is both a missed opportunity and
a largely unexplored area of research. Despite our
consolidated understanding of how financially disas-
trous it is to experience TB, we still know far less
about how social protection schemes could be made
accessible to TB patients, or how these could be
designed or adapted to best meet the needs of
households living with or at risk of TB.7
The above research agenda is urgent if the
consequences of TB are to be mitigated and, ideally,
prevented. The creation of strong and sustainable
partnerships with stakeholders outside the TB sector
will be key to making this research agenda affordable
and impactful.
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